| scholarly article | Q13442814 |
| P50 | author | Dae-Sik Lim | Q38304792 |
| Joo-Hyeon Lee | Q50623875 | ||
| Kwang-Pyo Lee | Q61101742 | ||
| Bon-Kyoung Koo | Q61208762 | ||
| Jin Man Kim | Q88051075 | ||
| Young-Yun Kong | Q89294464 | ||
| P2093 | author name string | Sang-Hee Lee | |
| Hyun-Jung Oh | |||
| Tae-Shin Kim | |||
| Sang-Phil Oh | |||
| Tae-Hong Yang | |||
| P2860 | cites work | Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity | Q22001459 |
| LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1 | Q24298040 | ||
| Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control | Q24299106 | ||
| A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator | Q24534123 | ||
| TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm | Q24632716 | ||
| Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 | ||
| RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein | Q24648062 | ||
| LATS1 tumor suppressor regulates G2/M transition and apoptosis | Q40750103 | ||
| Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway | Q44591663 | ||
| Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium | Q45345222 | ||
| RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. | Q45939520 | ||
| The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation | Q46192247 | ||
| The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. | Q47070421 | ||
| Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila | Q47072038 | ||
| Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. | Q47317241 | ||
| Proteolytic activation of MST/Krs, STE20-related protein kinase, by caspase during apoptosis | Q47852901 | ||
| Developmental gradient of cell cycle in the telencephalic roof of the fetal NMRI-mouse | Q48825786 | ||
| The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. | Q52100108 | ||
| The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. | Q52672613 | ||
| The human tumour suppressor LATS1 is activated by human MOB1 at the membrane | Q83287887 | ||
| Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila | Q24670738 | ||
| Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon | Q24682018 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1 | Q28116287 | ||
| salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines | Q28219379 | ||
| Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers | Q28237942 | ||
| Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product | Q28245300 | ||
| The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP | Q28266862 | ||
| Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma | Q28269109 | ||
| Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin | Q28275474 | ||
| Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction | Q28297172 | ||
| Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase | Q28301071 | ||
| The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation | Q28504969 | ||
| NF2deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions | Q28511556 | ||
| Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65 | Q28512949 | ||
| YAP1 increases organ size and expands undifferentiated progenitor cells | Q28592519 | ||
| Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity | Q28594156 | ||
| Regulation of cerebral cortical size by control of cell cycle exit in neural precursors | Q29615158 | ||
| Elucidation of a universal size-control mechanism in Drosophila and mammals | Q29618935 | ||
| The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis | Q29619851 | ||
| hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts | Q29620457 | ||
| Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane | Q30443407 | ||
| Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis | Q30478335 | ||
| From cell structure to transcription: Hippo forges a new path | Q33342058 | ||
| Calcium regulation of growth and differentiation of mouse epidermal cells in culture | Q34248695 | ||
| Control of cell proliferation and apoptosis by mob as tumor suppressor, mats | Q34402685 | ||
| The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis | Q34474913 | ||
| The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila | Q34559232 | ||
| The bantam microRNA is a target of the hippo tumor-suppressor pathway | Q34562924 | ||
| Delineation of a Fat tumor suppressor pathway | Q34566699 | ||
| Filling out the Hippo pathway | Q34648282 | ||
| The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis | Q36336754 | ||
| Epithelial stem cells: turning over new leaves | Q36690919 | ||
| The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network | Q36743530 | ||
| Hippo signaling in organ size control | Q36793377 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Yes-associated protein 1 | Q21498262 |
| Large tumor suppressor 2 | Q21987161 | ||
| Large tumor suppressor | Q21987164 | ||
| Serine/threonine kinase 4 | Q21989445 | ||
| Salvador family WW domain containing 1 | Q21991434 | ||
| P304 | page(s) | 1231–1242 | |
| P577 | publication date | 2008-04-23 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | A crucial role of WW45 in developing epithelial tissues in the mouse | |
| P478 | volume | 27 |
| Q36438072 | A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness |
| Q30843628 | A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells |
| Q28509403 | Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice |
| Q58693529 | Activation mechanisms of the Hippo kinase signaling cascade |
| Q36170597 | Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell |
| Q38232581 | An emerging role for Hippo-YAP signaling in cardiovascular development |
| Q38293195 | Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1. |
| Q64071683 | Cancer as an Embryological Phenomenon and Its Developmental Pathways: A Hypothesis regarding the Contribution of the Noncanonical Wnt Pathway |
| Q30530942 | Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice |
| Q38119565 | Capturing the mammalian Hippo: elucidating its role in cancer |
| Q28507073 | Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development |
| Q27323241 | Comparative study of Hippo pathway genes in cellular conveyor belts of a ctenophore and a cnidarian |
| Q24307199 | Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction |
| Q33373668 | Context-dependent requirement for dE2F during oncogenic proliferation |
| Q38514410 | Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway |
| Q28586255 | Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse |
| Q35539381 | Crystallization and preliminary X-ray crystallographic study of the human MST2 SARAH domain. |
| Q28578997 | Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling |
| Q34106752 | Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma |
| Q50612560 | Dual role of YAP and TAZ in renewal of the intestinal epithelium. |
| Q36459320 | Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. |
| Q37930997 | Emerging role for epithelial polarity proteins of the Crumbs family as potential tumor suppressors |
| Q38923539 | Emerging role of Hpo signaling and YAP in hepatocellular carcinoma |
| Q24657592 | Expression of Yes-associated protein in common solid tumors |
| Q90735622 | Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload |
| Q28269498 | Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer |
| Q35678520 | Hippo Stabilises Its Adaptor Salvador by Antagonising the HECT Ubiquitin Ligase Herc4. |
| Q42357377 | Hippo pathway in lung development |
| Q38283344 | Hippo signaling in epithelial stem cells |
| Q38283345 | Hippo signaling in stress response and homeostasis maintenance |
| Q28587974 | Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver |
| Q37375869 | Hippo signaling pathway and organ size control. |
| Q34625638 | Hippo signaling: growth control and beyond |
| Q53617792 | Hippo signalling directs intestinal fate. |
| Q90131230 | Hippo signalling during development |
| Q39081825 | Hippo vs. Crab: tissue-specific functions of the mammalian Hippo pathway |
| Q36835619 | Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis. |
| Q90463701 | Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine |
| Q36784391 | Identification of RUNX3 as a component of the MST/Hpo signaling pathway |
| Q51934816 | Imprinting analysis in the Acrodysplasia region of mouse chromosome 12. |
| Q35667652 | Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. |
| Q34406086 | Inherited MST1 deficiency underlies susceptibility to EV-HPV infections |
| Q47772615 | Integrin-FAK-CDC42-PP1A signaling gnaws at YAP/TAZ activity to control incisor stem cells |
| Q35378440 | KIBRA protein phosphorylation is regulated by mitotic kinase aurora and protein phosphatase 1. |
| Q40778207 | Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway |
| Q37061204 | LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development. |
| Q48577055 | Lats1 Deletion Causes Increased Germ Cell Apoptosis and Follicular Cysts in Mouse Ovaries |
| Q38724065 | MRTF potentiates TEAD-YAP transcriptional activity causing metastasis. |
| Q26787040 | MST kinases in development and disease |
| Q24300132 | MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling |
| Q33821181 | MST1/MST2 Protein Kinases: Regulation and Physiologic Roles |
| Q38037988 | Major signaling pathways in intestinal stem cells |
| Q37843031 | Mammalian Hippo pathway: from development to cancer and beyond |
| Q26849472 | Mammalian Hippo signalling: a kinase network regulated by protein-protein interactions |
| Q24315808 | Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling |
| Q24304151 | Mammalian ste20-like kinase and SAV1 promote 3T3-L1 adipocyte differentiation by activation of PPARγ |
| Q28283076 | Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival |
| Q24300770 | Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus |
| Q88801478 | Molecular Pathogenesis of Pancreatic Cancer |
| Q30369861 | Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor. |
| Q35469289 | Molecular mechanism of size control in development and human diseases |
| Q42064207 | Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene |
| Q21091167 | Mst1-FoxO signaling protects Naïve T lymphocytes from cellular oxidative stress in mice |
| Q37811893 | Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development |
| Q42830266 | NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway |
| Q35605297 | Negative regulation of Yap during neuronal differentiation |
| Q104069878 | Neuronal Hippo Signaling: From Development to Diseases |
| Q36371333 | Protein kinases of the Hippo pathway: regulation and substrates |
| Q37087082 | RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer |
| Q38132299 | Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling |
| Q30417692 | Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1 |
| Q34986206 | Regulation of organ size: insights from the Drosophila Hippo signaling pathway |
| Q49797883 | Regulation of the Hippo Signaling Pathway by Ubiquitin Modification |
| Q88229231 | Regulation of the Hippo pathway in cancer biology |
| Q55384318 | Role and inhibition of GLI1 protein in cancer. |
| Q36478653 | Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. |
| Q38137820 | Role of Hippo signaling in cancer stem cells. |
| Q39003420 | Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies |
| Q34998037 | Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions |
| Q41544383 | Signal integration in TGF-β, WNT, and Hippo pathways |
| Q46320040 | Single-cell gene expression of the bovine blastocyst. |
| Q24603986 | The Hippo Signaling Pathway in Development and Cancer |
| Q35168762 | The Hippo pathway controls a switch between retinal progenitor cell proliferation and photoreceptor cell differentiation in zebrafish |
| Q37800053 | The Hippo pathway in biological control and cancer development |
| Q37909890 | The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal |
| Q33628097 | The Hippo pathway in tissue homeostasis and regeneration |
| Q38006856 | The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation |
| Q38083640 | The Hippo pathway: regulators and regulations |
| Q30410176 | The Hippo signaling pathway in stem cell biology and cancer |
| Q33929406 | The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. |
| Q28281214 | The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version |
| Q35811415 | The Hippo-YAP pathway: new connections between regulation of organ size and cancer |
| Q36098959 | The Hippo/MST Pathway Member SAV1 Plays a Suppressive Role in Development of the Prehierarchical Follicles in Hen Ovary |
| Q39394211 | The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway |
| Q26744308 | The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair |
| Q42468036 | The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis |
| Q47316032 | The emerging role of Hippo signaling pathway in regulating osteoclast formation. |
| Q34470968 | The hippo pathway in heart development, regeneration, and diseases |
| Q38285451 | The regulation and function of YAP transcription co-activator |
| Q47754394 | Transit-amplifying cell frequency and cell cycle kinetics are altered in aged epidermis |
| Q54973587 | Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer. |
| Q37708883 | WW45, a Gli1 binding protein, negatively regulated Hedgehog signaling in lung cancer |
| Q39915491 | YAP regulates neural progenitor cell number via the TEA domain transcription factor |
| Q34950066 | YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease |
| Q43007023 | YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation |
| Q92382004 | YAP1 is involved in replenishment of granule cell precursors following injury to the neonatal cerebellum |
| Q27323992 | Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development |
| Q34573137 | Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin |
| Q36682016 | Yes-associated protein (yap) is required for early embryonic development in zebrafish (danio rerio) |
| Q36898504 | cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. |
Search more.